norfloxacin has been researched along with Schistosomiasis in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Schistosomiasis: Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Selective intestinal decontamination (SID) for 7 days with norfloxacin (NF) was performed in 15 patients with schistosomal hepatic fibrosis (SHF) and low-protein ascites." | 5.07 | Selective intestinal decontamination in patients with schistosomal hepatic fibrosis and low-protein ascites. ( Abou Seif Helmy, M; el Aggan, HA; el-Aggan, HA; Guirguis, TG, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| el Aggan, HA | 1 |
| el-Aggan, HA | 1 |
| Abou Seif Helmy, M | 1 |
| Guirguis, TG | 1 |
1 trial available for norfloxacin and Schistosomiasis
| Article | Year |
|---|---|
Selective intestinal decontamination in patients with schistosomal hepatic fibrosis and low-protein ascites.
Topics: Adult; Animals; Ascites; Ascitic Fluid; Humans; Intestines; Liver Cirrhosis; Norfloxacin; Peritoniti | 1993 |